analyst

NASDAQ · OCUL
Ocular Therapeutix, Inc.
Healthcare · Biotechnology
$7.38
Up+$0.18 (+2.50%)
Updated Oct 16, 2026, 7:23 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.55B
- P/E ratio
- -10.81
- Dividend yield
- 0.00%
- 52-week range
- $6.23 – $16.44
- Volume
- 3.25M
- Avg. volume
- 3.15M
Price performance · OCUL
OCUL price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 15, 2026
OCUL closed at $7.38 after 21 trading sessions, down 27.22% for the selected period.
- Last close
- $7.38
- Period change
- -27.22%
- Period low
- $6.96
- Period high
- $10.50
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | $7.29 | $7.465 | $7.23 | $7.38 | 3.25M |
| Oct 14, 2026 | $7.14 | $7.30 | $7.07 | $7.20 | 2.21M |
| Oct 13, 2026 | $7.55 | $7.61 | $7.20 | $7.24 | 3.22M |
| Oct 12, 2026 | $7.60 | $7.75 | $7.36 | $7.56 | 3.67M |
| Oct 9, 2026 | $7.49 | $7.68 | $7.38 | $7.54 | 2.63M |
| Oct 8, 2026 | $7.20 | $7.565 | $7.06 | $7.51 | 3.9M |
| Oct 7, 2026 | $7.26 | $7.545 | $7.19 | $7.23 | 2.93M |
| Oct 6, 2026 | $7.30 | $7.565 | $7.13 | $7.34 | 2.81M |
| Oct 5, 2026 | $6.93 | $7.27 | $6.79 | $7.25 | 5.62M |
| Oct 2, 2026 | $7.40 | $7.425 | $6.935 | $6.96 | 4.96M |
| Oct 1, 2026 | $7.63 | $7.705 | $7.26 | $7.29 | 4.51M |
| Sep 30, 2026 | $7.88 | $8.1594 | $7.6338 | $7.67 | 4.57M |
| Sep 29, 2026 | $7.80 | $8.13 | $7.5101 | $7.87 | 5.29M |
| Sep 28, 2026 | $9.38 | $9.38 | $7.18 | $7.655 | 15.44M |
| Sep 25, 2026 | $9.77 | $9.85 | $9.585 | $9.65 | 1.62M |
| Sep 24, 2026 | $9.94 | $9.98 | $9.60 | $9.82 | 1.86M |
| Sep 23, 2026 | $10.48 | $10.57 | $9.77 | $10.00 | 2.09M |
| Sep 22, 2026 | $10.08 | $10.61 | $10.02 | $10.50 | 2.5M |
| Sep 21, 2026 | $10.08 | $10.17 | $9.81 | $9.99 | 2.07M |
| Sep 18, 2026 | $10.15 | $10.26 | $9.895 | $9.99 | 4.1M |
| Sep 17, 2026 | $10.11 | $10.545 | $10.055 | $10.14 | 2.31M |
Latest OCUL news
The latest Smart Investors Daily articles mentioning OCUL.
Stock researchCompany · Overview
Company
Market Activity
Research & News
Loading stock research…

